Bio-Connect

CRMP5 antibody [N1C1]

GTX112287
GeneTex
ApplicationsImmunoFluorescence, Western Blot, ImmunoCytoChemistry, ImmunoHistoChemistry, ImmunoHistoChemistry Paraffin
Product group Antibodies
TargetDPYSL5
Sign in to order and to see your custom pricing.
Large volume orders?
Order with a bulk request

Overview

  • Supplier
    GeneTex
  • Product Name
    CRMP5 antibody [N1C1]
  • Delivery Days Customer
    9
  • Application Supplier Note
    WB: 1:500-1:20000. ICC/IF: 1:100-1:1000. IHC-P: 1:100-1:1000. *Optimal dilutions/concentrations should be determined by the researcher.Not tested in other applications.
  • Applications
    ImmunoFluorescence, Western Blot, ImmunoCytoChemistry, ImmunoHistoChemistry, ImmunoHistoChemistry Paraffin
  • Certification
    Research Use Only
  • Clonality
    Polyclonal
  • Concentration
    1.01 mg/ml
  • Conjugate
    Unconjugated
  • Gene ID56896
  • Target name
    DPYSL5
  • Target description
    dihydropyrimidinase like 5
  • Target synonyms
    CRAM, CRMP-5, CRMP5, CV2, RTSC4, Ulip6, dihydropyrimidinase-related protein 5, CRMP3-associated molecule, DRP-5, ULIP-6, UNC33-like phosphoprotein 6, collapsin response mediator protein-5
  • Host
    Rabbit
  • Isotype
    IgG
  • Protein IDQ9BPU6
  • Protein Name
    Dihydropyrimidinase-related protein 5
  • Scientific Description
    Members of the CRMP family, such as DPYSL5, are believed to play a role in growth cone guidance during neural development.[supplied by OMIM]
  • Storage Instruction
    -20°C or -80°C,2°C to 8°C
  • UNSPSC
    12352203

References

  • Zeng HY, Liu Q, Peng XY, et al. Detection of serum anti-retinal antibodies in the Chinese patients with presumed autoimmune retinopathy. Graefes Arch Clin Exp Ophthalmol. 2019,257(8):1759-1764. doi: 10.1007/s00417-019-04359-2
    Read this paper
  • Saito M, Saito W, Kanda A, et al. A case of paraneoplastic optic neuropathy and outer retinitis positive for autoantibodies against collapsin response mediator protein-5, recoverin, and α-enolase. BMC Ophthalmol. 2014,14:5. doi: 10.1186/1471-2415-14-5
    Read this paper